Literature DB >> 12441773

Recurrent fatal drug-induced toxic epidermal necrolysis (Lyell's syndrome) after putative beta-lactam cross-reactivity: Case report and scrutiny of antibiotic imputability.

Philippe Paquet1, Eric Jacob, Pierre Damas, Gérald E Piérard.   

Abstract

OBJECTIVE: A series of antibiotics may be responsible for toxic epidermal necrolysis. We report two successive episodes of toxic epidermal necrolysis in the same patient. Drug imputability criteria designate a cross-reactivity between two antibiotics of different chemical classes but sharing the beta-lactam ring in common.
DESIGN: Descriptive case report and review of the literature.
SETTING: Medical intensive care unit in a university medical center. PATIENT AND MAIN
RESULTS: A 75-yr-old woman developed a first episode of toxic epidermal necrolysis (involving 40% of the body surface) after intake of cefotaxime, a third-generation cephalosporin. Perfusions of high-dose immunoglobulins rapidly improved the lesions, followed by partial reepithelialization in 5 days. Sepsis required the administration of meropenem, which is a carbapenem antibiotic. The epidermal destruction immediately recurred, with extension to previously uninvolved skin areas and fatal consequences.
CONCLUSIONS: The beta-lactam ring present in cephalosporins and carbapenems represents the putative chemical structure responsible for the presently reported cross-reactivity to two antibiotics of different classes. Drugs having any chemical similarity to the initial culprit compound should be strictly avoided when possible in the management of toxic epidermal necrolysis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441773     DOI: 10.1097/00003246-200211000-00029

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  4 in total

1.  Toxic Epidermal Necrolysis Managed with Immunoglobulin: Reply.

Authors:  G D Choudhury; Vikas Agarwal
Journal:  Med J Armed Forces India       Date:  2011-07-21

2.  Attention to TEN.

Authors:  Sanjiv Grover
Journal:  Med J Armed Forces India       Date:  2011-07-21

3.  New insights in toxic epidermal necrolysis (Lyell's syndrome): clinical considerations, pathobiology and targeted treatments revisited.

Authors:  Philippe Paquet; Gérald E Piérard
Journal:  Drug Saf       Date:  2010-03-01       Impact factor: 5.606

4.  Retrospective Analysis of Corticosteroid Treatment in Stevens-Johnson Syndrome and/or Toxic Epidermal Necrolysis over a Period of 10 Years in Vajira Hospital, Navamindradhiraj University, Bangkok.

Authors:  Wanjarus Roongpisuthipong; Sirikarn Prompongsa; Theerawut Klangjareonchai
Journal:  Dermatol Res Pract       Date:  2014-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.